Corynebacterium atypicum sp. nov., from a human clinical source, does not contain corynomycolic acids

Hall, V., Collins, M.D., Hutson, R.A., Lawson, P.A., Falsen, E. and Duerden, B.I. (2003) Corynebacterium atypicum sp. nov., from a human clinical source, does not contain corynomycolic acids. International Journal of Systematic and Evolutionary Microbiology, 53 (4). pp. 1065-1068. ISSN 1466-5026 doi: 10.1099/ijs.0.02442-0

Abstract/Summary

An unusual Gram-positive, facultatively anaerobic, catalase-positive, diphtheroid-shaped organism originating from an unknown human clinical source was characterized by biochemical, molecular chemical and molecular phylogenetic methods. Based on its morphological and biochemical characteristics and the presence of a murein based on meso-diaminopimelic acid, the unidentified organism was tentatively assigned to the genus Corynebacterium. However, the unknown organism was found to lack the distinctive, short-chain corynomycolic acids that are considered to be characteristic of this genus. Despite the absence of these characteristic lipids, comparative 16S rRNA gene sequencing showed that the unknown bacterium was phylogenetically a member of the genus Corynebacterium and was distinct from all currently known species. Based on both phenotypic and 16S rRNA sequence considerations, it is proposed that the unknown organism be classified as a novel species, Corynebacterium atypicum sp. nov. The type strain of C. atypicum is strain R2070(T) (= CCUG 45804(T) = CIP 107431(T)).